- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04867668
Digital Media for Cancer Control (to Prevent Vaping and Smoking Behavior) (DMCC)
March 9, 2026 updated by: W.Douglas Evans, George Washington University
Digital Media for Cancer Control: Randomized Controlled Trial and Dose-Response Effects
There is little published data on exposure to and evaluations of large-scale, online tobacco control campaigns.
This project addresses the gap.
Under 2 specific aims, the investigators will identify the independent effects of varying levels of digital message exposure to promote anti-tobacco attitudes, beliefs, or behaviors among youth and young adults, first through a randomized experiment online, and second through a field-based evaluation.
These studies will advance the science of digital health and have wide application to future campaigns.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Tobacco remains the single leading preventable cause of death in the US and annual tobacco-related health care costs are estimated at $170 billion.
In 2016, 20% of high school students (3.05 million youth) reported recent use of tobacco products and estimated 5.6 million youth under the age of 18 will die early due to smoking-related illness demonstrating a need for prevention interventions.
According to the Center for Disease Control and Prevention, some 13.1% of adults aged 18-24 were smokers, and over 5 million of these young adults will die early due to smoking-related illness.
Moreover, the significant declines in youth cigarette smoking may be eclipsed by other tobacco products and use of JUUL, a highly-effective nicotine delivery product.
Given their widespread use, there is a need to leverage digital media to influence health outcomes and public education campaigns are increasingly using them.
Recent studies show that social media can be effective in countering tobacco industry product promotion online and as a tobacco control campaign platform.
However, there is little published data on exposure to and evaluations of large-scale, online tobacco control campaigns.
The proposed R01 project addresses this gap and builds on over 16 years of collaboration among the research team in evaluating the national Truth campaign.
This application is significant for several reasons.
First, tobacco use prevention and other health behavior change campaigns are increasingly delivered through digital channels, yet few studies have focused on rigorous measurement of digital message exposure and response.
Exposure measures are a critical component since analyses either compare those exposed to the unexposed, or examine a dose-response curve among varying levels of campaign exposure.
This research will use pixel tracking (HTML codes embedded in digital ads) to measure campaign dose-response effects.
While the predictive value of self-report and exogenous mass media measures of exposure (e.g., Gross Rating Points) has been well studied, there is little evidence on the effects of digital exposure.
Finally, little is known about the independent effects of varying levels of digital message exposure to promote anti-tobacco attitudes, beliefs, or behaviors among youth and young adults.
In aim 1, the investigators will conduct a 6-month controlled, online, randomized study to compare the effects of varying levels of digital media exposure, measured by pixel tracking, on campaign-targeted tobacco-related knowledge, attitudes, beliefs and behavioral outcomes.
In aim 2, the investigators will conduct a field-based randomized trial to evaluate a truth digital campaign to confirm the relationship between digital media exposure, message awareness, and tobacco-related outcomes over 36 months.
The result of these studies will be benchmark methods and measures of digital ad exposure that have wide application to future digital health campaigns.
Study Type
Interventional
Enrollment (Actual)
2800
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
District of Columbia
-
Washington D.C., District of Columbia, United States, 20052
- The George Washington University Milken Institute School of Public Health
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 24 years (Adult)
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- Young adults age 18-24 who are members of the Ipsos/Knowledge Panel
Exclusion Criteria:
- Those who do not meet inclusion criteria
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Factorial Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Digital intervention
Participants will be randomized to receive variable levels of exposure (including no exposure control) of digital anti-vaping and anti-smoking messages.
We will evaluate the effects of experimental condition and exposure on outcomes (tobacco product use).
|
Delivery of social media based advertising to prevent vaping and smoking among young adults ages 18-24.
|
|
No Intervention: Control
No exposure control condition
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
30-day use of electronic cigarettes (vaping)
Time Frame: Ad Awareness Outcome (Aim 1): By the end of year 1, Vaping & Smoking Outcome (Aim 2): By the end of year 5
|
Frequency of vaping during the past 30 days
|
Ad Awareness Outcome (Aim 1): By the end of year 1, Vaping & Smoking Outcome (Aim 2): By the end of year 5
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- Evans WD, Ichimiya M, Bingenheimer JB, Cantrell J, D'Esterre AP, Pincus O, Yu LQ, Hair EC. Design and Baseline Evaluation of Social Media Vaping Prevention Trial: Randomized Controlled Trial Study. J Med Internet Res. 2025 Mar 31;27:e72002. doi: 10.2196/72002.
- Evans WD, Bingenheimer J, Cantrell J, Kreslake J, Tulsiani S, Ichimiya M, D'Esterre AP, Gerard R, Martin M, Hair EC. Effects of a Social Media Intervention on Vaping Intentions: Randomized Dose-Response Experiment. J Med Internet Res. 2024 Mar 12;26:e50741. doi: 10.2196/50741.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
February 20, 2021
Primary Completion (Actual)
February 28, 2026
Study Completion (Actual)
February 28, 2026
Study Registration Dates
First Submitted
February 1, 2021
First Submitted That Met QC Criteria
April 29, 2021
First Posted (Actual)
April 30, 2021
Study Record Updates
Last Update Posted (Actual)
March 10, 2026
Last Update Submitted That Met QC Criteria
March 9, 2026
Last Verified
March 1, 2026
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- NCR202837
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Tobacco Use
-
Loma Linda UniversityUniversity of California, San Francisco; Riverside University Health System...RecruitingTobacco Use | Tobacco Use Cessation | Tobacco Use in ChildbirthUnited States
-
University of Mississippi Medical CenterNot yet recruitingTobacco Cessation
-
University of California, San FranciscoTobacco Related Disease Research ProgramRecruitingTobacco Cessation | Tobacco Use | Tobacco Use Cessation | Tobacco Dependence | Tobacco AbstinenceUnited States
-
Juul Labs, Inc.CompletedTobacco Use | Tobacco Smoking | Electronic Cigarette Use | Cigarette Use, ElectronicUnited States
-
Juul Labs, Inc.CompletedTobacco Use | Tobacco Smoking | Electronic Cigarette Use | Cigarette Use, ElectronicUnited States
-
Mayo ClinicNational Institute on Drug Abuse (NIDA)CompletedSmoking | Smoking Cessation | Tobacco Use | Tobacco Smoking | Tobacco Use Cessation | Smoking, Tobacco | Smoking, CigaretteUnited States
-
Duke UniversityCompletedSmokeless Tobacco CessationUnited States
-
University of FloridaRecruitingTobacco Use | Nicotine UseUnited States
-
Claremont Graduate UniversityNational Cancer Institute (NCI)CompletedSmoking | Smoking Cessation | Tobacco Use | Tobacco Smoking | Tobacco Use Cessation | Smoking, CigaretteUnited States
-
Rutgers, The State University of New JerseyNational Cancer Institute (NCI)CompletedTobacco Product Beliefs and UseUnited States
Clinical Trials on Anti-vaping and anti-smoking digital advertising
-
University of California, Los AngelesNational Heart, Lung, and Blood Institute (NHLBI); National Institutes of Health...CompletedInflammation | Endothelial Dysfunction | Oxidative StressUnited States
-
University of MinnesotaWithdrawnHealthy Volunteers | Vaping | Smokers
-
University of GeorgiaRecruitingMessage Exposure (Sequence: Regular Then Flavor) | Message Exposure (Sequence: Flavor Then Regular) | No Message Exposure (Control Condition)United States
-
Roswell Park Cancer InstituteNational Cancer Institute (NCI)TerminatedTobacco-Related CarcinomaUnited States
-
State University of New York at BuffaloNational Institute on Drug Abuse (NIDA); Roswell Park Cancer InstituteRecruitingAcute Abstinence From Cigarettes vs E-cigarettes (ENDS)United States
-
State University of New York at BuffaloNational Institute on Drug Abuse (NIDA); Roswell Park Cancer InstituteRecruitingAcute Abstinence From Cigarettes vs E-cigarettes (ENDS)United States
-
Eunice Kennedy Shriver National Institute of Child...Completed
-
University of Southern CaliforniaNational Institute on Drug Abuse (NIDA); National Cancer Institute (NCI)CompletedAdolescent | Electronic Cigarette Use | Cannabis | Nicotine | VapingUnited States
-
Abramson Cancer Center at Penn MedicineNational Cancer Institute (NCI); Dana-Farber Cancer Institute; Stanford University and other collaboratorsCompletedCigarette Smoking BehaviorUnited States
-
University of California, San FranciscoNational Cancer Institute (NCI)Completed